Results 31 to 40 of about 826,967 (302)

Firm-Level Exposure to Epidemic Diseases: Covid-19, Sars, and H1n1

Institute for New Economic Thinking Working Paper Series, 2020
Using tools described in our earlier work (Hassan et al., 2019, 2020), we develop text- based measures of the costs, benefits, and risks listed firms in the US and over 80 other countries associate with the spread of Covid-19 and other epidemic diseases.
T. Hassan, Stephan Hollander, Laurence van Lent, Tahoun Tahoun   +3 more
semanticscholar   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter

Cureus, 2020
Background Since the beginning of the coronavirus disease 2019 (COVID-19) epidemic, misinformation has been spreading uninhibited over traditional and social media at a rapid pace. We sought to analyze the magnitude of misinformation that is being spread
Ramez Kouzy, J. Abi Jaoude, A. Kraitem, Molly B. El Alam, Basil S. Karam, E. Adib, Jabra Zarka, C. Traboulsi, E. Akl, Khalil Baddour   +9 more
semanticscholar   +1 more source

Programmable DNA‐Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes

Advanced Functional Materials, EarlyView.
A multivalent antiviral platform based on honeycomb‐shaped DNA nanostructures (HC–Urumin) is developed to enhance the potency and breadth of the host defense peptide Urumin. Through spatially patterned trimeric presentation, HC–Urumin disrupts influenza A virus entry, improves cell viability, and reduces disease severity in vivo‐offering a modular and ...
Saurabh Umrao, Abhisek Dwivedy, Payton L. Haak, Dhanush Gandavadi, Laurie A. Rund, Chi Chen, Vineetha Mareddy, Lifeng Zhou, Jinwei Duan, Ying Fang, Andrew J. Steelman, Xing Wang   +11 more
wiley   +1 more source

Population-Based Propensity Score-Matched Analysis of Paxlovid and Molnupiravir Effectiveness in High-Risk COVID-19 Patients

International Journal of Infectious Diseases
Introduction: COVID-19 poses a severe threat to high-risk populations, such as the elderly and those with incomplete vaccination. Despite the availability of treatments like Paxlovid and Molnupiravir, their relative effectiveness in preventing severe ...
Dr Yi-hsuan Chen, Dr Cheng-Yi Lee, Dr Hao-Yuan Cheng, Mr. Yu-Neng Cheuh, Mr. Hung-Wei Kuo   +4 more
doaj   +1 more source

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, EarlyView.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

Generation of an Induced Pluripotent Stem Cell‐Derived Alveolar Type II In Vitro Model to Study Influenza A Virus Infection and Drug Treatments

Advanced Healthcare Materials, EarlyView.
Patient‐specific induced pluripotent stem cells (iPSCs) can be differentiated into alveolar type II cells (iAT2s), expanded as 3D alveolospheres, and grown at physiologically relevant air–liquid interface (ALI). This study shows for the first time the infectability of iAT2s by the influenza A virus (IAV) and proves their responsiveness to the well ...
Lena Gauthier, Hristina Koceva, Yann Bachelot, Rosanne W. Koutstaal, Puck B. van Kasteren, Marc Thilo Figge, Christian Eggeling, Alexander Sandy Mosig   +7 more
wiley   +1 more source

Informed decisions about public health and social measures

Health Research Policy and Systems
Evidence, communication, critical thinking and participation are the cornerstones of informed decisions. In this article we discuss each of these in relation to decisions about public health and social measures (PHSM) during the coronavirus disease 2019 (
Andrew D. Oxman, Annlaug Selstø, Arnfinn Helleve, Atle Fretheim, Cathinka Halle Julin, Christine Holst, Christopher James Rose, Heather Munthe-Kaas, Ingeborg Hess Elgersma, Jenny Moberg, Mona Bjørbæk, Petter Elstrøm, Runar Barstad Solberg, Sarah E. Rosenbaum, Signe Flottorp, Tone Bruun, Unni Gopinathan   +16 more
doaj   +1 more source

Risk factors and mortality of SARS-CoV-2 reinfection during the Omicron era in Taiwan: A nationwide population-based cohort study

Journal of Microbiology, Immunology and Infection
Background: Prior to 2022, Taiwan had effectively contained the domestic COVID-19 epidemic. However, during 2022, the country encountered multiple large outbreaks of COVID-19, with patients experiencing their first or second infection (reinfection) were ...
Yi-Hsuan Chen, Cheng-Yi Lee, Hao-Yuan Cheng, Chiu-Mei Chen, Yu-Neng Cheuh, Chia-Lin Lee, Hung-Wei Kuo   +6 more
doaj   +1 more source

Characteristics of 110 novel SARS-CoV-2 variant infections confirmed during February – May, 2023 in a district of Beijing

Zhongguo gonggong weisheng, 2023
ObjectiveTo describe clinical and epidemiological characteristics of cases infected with novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant diagnosed during February – May, 2023 in a district of Beijing city for effective ...
Ruiqi HAO, Zhiyuan XU, Xiaofeng ZHANG, Jianrong CHEN, Meng ZHANG, Xiaohong JIANG, Xiao QI   +6 more
doaj   +1 more source